Share Hutch News

Fred Hutch physician-scientist Dr. Pete Nelson has participated in every Obliteride since the event’s inception five years ago, teaming up with a core group of prostate-cancer researchers and cancer survivors for fun with a distinct purpose: benefiting patients.

At Fred Hutch News Service, our writers witness daily the excitement of covering new developments in the science of cancer and the human immune system. As 2016 draws to a close, we asked them to sort through the stories about Fred Hutch research they had written this year, and offer our readers a selection of those they felt were most meaningful and important.

Good News: Halloran honored in Rome; Hutch nominated for nonprofit of the year; Obliteride amassed $2.4M.

This weekend’s fourth annual Obliteride fundraising bike ride for Fred Hutch involved more than 1,500 riders who have so far raised nearly $2 million for Fred Hutch’s cancer research, with donations continuing to roll in for the next month.

The fourth annual Obliteride, the fundraising bike ride that supports research at Fred Hutch, is taking place this weekend. More than 1,400 riders, many of whom are living with cancer or are cancer survivors, have signed up to participate. Here are three of their stories.

By ones and twos and threes and fives, more than a thousand Obliteride riders rolled into Seattle’s Gas Works Park on Sunday, marking the end of a triumphant weekend of bicycle-borne determination to fight back against cancer.